Press Releases :: Sutro Biopharma, Inc. (STRO)

Nov 24, 2020 7:00 am EST

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer

Nov 18, 2020 7:00 am EST

Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations

Nov 11, 2020 7:00 am EST

Sutro Biopharma to Participate in Four Upcoming Investor Conferences

Nov 5, 2020 7:00 am EST

Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments

Sep 21, 2020 7:00 am EDT

Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC

Sep 9, 2020 4:01 pm EDT

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting

Sep 3, 2020 7:00 am EDT

Sutro Biopharma to Present at Two Upcoming Investor Conferences

Sep 2, 2020 4:12 pm EDT

Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting

Aug 25, 2020 7:00 am EDT

Sutro Biopharma Earns Clinical Supply Milestone Payment from Merck KGaA, Darmstadt, Germany for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors

Aug 11, 2020 7:00 am EDT

Sutro Biopharma Announces Two Executive Promotions to Vice President of Quality and Vice President of Manufacturing